CK5/6 negativity in non‐muscle‐invasive papillary upper tract urothelial carcinoma hurt patient survival [40], but in invasive breast cancer, CK5/6 positivity harmed patient disease‐free survival (DFS) [41]. This evidence concerns the gene KRT5 and invasive breast carcinoma.